0001140361-18-012133.txt : 20180305
0001140361-18-012133.hdr.sgml : 20180305
20180305212131
ACCESSION NUMBER: 0001140361-18-012133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180305
DATE AS OF CHANGE: 20180305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Anthony
CENTRAL INDEX KEY: 0001606030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 18668508
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc1.xml
FORM 4
X0306
4
2018-03-01
0
0000730272
REPLIGEN CORP
RGEN
0001606030
Hunt Anthony
C/O REPLIGEN CORPORATION
41 SEYON ST, BLDG 1, STE 100
WALTHAM
MA
02453
1
1
0
0
Chief Executive Officer
Common Stock
2018-03-01
4
A
0
38382
0.00
A
113170
D
Common Stock
2018-03-01
4
A
0
147623
0.00
A
260793
D
Stock Option (Right to Buy)
33.87
2018-03-01
4
A
0
74246
0.00
A
2028-03-01
Common Stock
74246
74246
D
Stock Option (Right to Buy)
33.87
2018-03-01
4
A
0
285563
0.00
A
2028-03-01
Common Stock
285563
285563
D
Mr. Hunt was awarded 38,382 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock.The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Mr. Hunt was awarded 147,623 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock.The Restricted Stock Units vest in equal annual installments over a nine-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.
The shares vest in equal annual installments over a nine-year period beginning on the first anniversary of the grant date.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2018-03-05